You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

HIV/AIDS: Adolescent and Adult Patients who are Prescribed Potent Antiretroviral Therapy

Percentage of patients with a diagnosis of HIV/AIDS, with at least two visits during the measurement year, with at least 90 days between each visit: aged 13 years and older who have a history of a CD4 count less than or equal to 500 cells/mm3; aged 13 years and older who have a history of an AIDS-defining illness, regardless of CD4 count; or who are pregnant, regardless of CD4 count or age, who were prescribed potent antiretroviral therapy

Date Reviewed: July 26, 2014

Measure Info

NQF 0406CMS 161NQF Endorsement Removed
Measure Type: 
Process
Measure Steward: 
National Committee for Quality Assurance
Clinical Topic Area: 
HIV

Care Setting: 
Outpatient
Data Source: 
Claims
Electronic Health Data
Electronic Health Records

ACP does not support PQRS 161: “HIV/AIDS: Adolescent and Adult Patients who are Prescribed Potent Antiretroviral Therapy” because the standard for determining which combinations of drugs could be considered “potent” is not described in adequate detail, and the need to assess viral genotype in choosing therapies is not mentioned.

As part of an ongoing effort to improve user experience, we have made some updates to the Performance Measures section of ACP. Tell us what you think!